Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)
5.74
-0.04 (-0.69%)
Apr 29, 2025, 2:45 PM CST
SHE:300318 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 851.69 | 998.91 | 751.6 | 682.18 | 723.17 | Upgrade
|
Other Revenue | - | 46.52 | 44.33 | 32.57 | 15.54 | Upgrade
|
Revenue | 851.69 | 1,045 | 795.93 | 714.75 | 738.72 | Upgrade
|
Revenue Growth (YoY) | -18.53% | 31.35% | 11.36% | -3.25% | 17.57% | Upgrade
|
Cost of Revenue | 433.61 | 593.97 | 542.42 | 422.28 | 385.56 | Upgrade
|
Gross Profit | 418.08 | 451.46 | 253.51 | 292.47 | 353.16 | Upgrade
|
Selling, General & Admin | 286 | 306.15 | 269.64 | 308.94 | 265.39 | Upgrade
|
Research & Development | 52.52 | 69.2 | 64.78 | 81.48 | 48.18 | Upgrade
|
Other Operating Expenses | 7.49 | 15.84 | 15.96 | 13.41 | 11.3 | Upgrade
|
Operating Expenses | 346.01 | 392.5 | 352.67 | 404.44 | 326.96 | Upgrade
|
Operating Income | 72.07 | 58.97 | -99.16 | -111.98 | 26.21 | Upgrade
|
Interest Expense | - | -27.62 | -42.25 | -45.06 | -35.44 | Upgrade
|
Interest & Investment Income | 1.15 | 4.78 | 0.51 | 4.97 | 5.49 | Upgrade
|
Currency Exchange Gain (Loss) | - | -0.45 | -1.07 | -0.45 | -0.01 | Upgrade
|
Other Non Operating Income (Expenses) | -52.88 | -8.74 | -6.79 | -3.98 | 0.82 | Upgrade
|
EBT Excluding Unusual Items | 20.34 | 26.94 | -148.76 | -156.5 | -2.93 | Upgrade
|
Impairment of Goodwill | - | - | -15.92 | -340.68 | -0.32 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | - | 0.09 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.12 | 1.11 | 31.97 | 0.14 | 0.19 | Upgrade
|
Asset Writedown | -0.55 | -3.31 | -1.61 | -20.43 | -0.16 | Upgrade
|
Other Unusual Items | - | 8.98 | 0.55 | 13.29 | 3.72 | Upgrade
|
Pretax Income | 19.91 | 33.73 | -133.78 | -504.18 | 0.59 | Upgrade
|
Income Tax Expense | 11.23 | 18.05 | 4.39 | 1.61 | 8.14 | Upgrade
|
Earnings From Continuing Operations | 8.68 | 15.68 | -138.17 | -505.79 | -7.55 | Upgrade
|
Minority Interest in Earnings | 0.57 | -40.61 | 59.73 | 183.61 | 15.06 | Upgrade
|
Net Income | 9.25 | -24.93 | -78.44 | -322.18 | 7.5 | Upgrade
|
Net Income to Common | 9.25 | -24.93 | -78.44 | -322.18 | 7.5 | Upgrade
|
Net Income Growth | - | - | - | - | 195.11% | Upgrade
|
Shares Outstanding (Basic) | 818 | 817 | 817 | 817 | 816 | Upgrade
|
Shares Outstanding (Diluted) | 818 | 817 | 817 | 817 | 816 | Upgrade
|
Shares Change (YoY) | 0.11% | 0.03% | 0.03% | 0.15% | -0.56% | Upgrade
|
EPS (Basic) | 0.01 | -0.03 | -0.10 | -0.39 | 0.01 | Upgrade
|
EPS (Diluted) | 0.01 | -0.03 | -0.10 | -0.39 | 0.01 | Upgrade
|
EPS Growth | - | - | - | - | 196.77% | Upgrade
|
Free Cash Flow | -227.64 | -60.53 | -120.74 | -366.17 | -116.2 | Upgrade
|
Free Cash Flow Per Share | -0.28 | -0.07 | -0.15 | -0.45 | -0.14 | Upgrade
|
Gross Margin | 49.09% | 43.18% | 31.85% | 40.92% | 47.81% | Upgrade
|
Operating Margin | 8.46% | 5.64% | -12.46% | -15.67% | 3.55% | Upgrade
|
Profit Margin | 1.09% | -2.38% | -9.86% | -45.08% | 1.02% | Upgrade
|
Free Cash Flow Margin | -26.73% | -5.79% | -15.17% | -51.23% | -15.73% | Upgrade
|
EBITDA | 166.4 | 158.21 | 6.53 | -7.09 | 116.13 | Upgrade
|
EBITDA Margin | 19.54% | 15.13% | 0.82% | -0.99% | 15.72% | Upgrade
|
D&A For EBITDA | 94.32 | 99.25 | 105.69 | 104.89 | 89.93 | Upgrade
|
EBIT | 72.07 | 58.97 | -99.16 | -111.98 | 26.21 | Upgrade
|
EBIT Margin | 8.46% | 5.64% | -12.46% | -15.67% | 3.55% | Upgrade
|
Effective Tax Rate | 56.41% | 53.51% | - | - | 1390.93% | Upgrade
|
Revenue as Reported | - | 1,045 | 795.93 | 714.75 | 738.72 | Upgrade
|
Advertising Expenses | - | 17.36 | 14.71 | 31.57 | 47.49 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.